Silk Fibroin Biomaterial Market Worth $4.7 billion by 2033According to our latest research, the Global Silk Fibroin Biomaterial market size was valued at $1.2 billion in 2024 and is projected to reach $4.7 billion by 2033, expanding at a remarkable CAGR of 16.8% during the forecast period of 2024–2033. The primary driver fueling this impressive growth is the rapidly increasing demand for biocompatible and biodegradable materials across medical, pharmaceutical, and cosmetic applications. Silk fibroin, derived from the silk of the Bombyx mori silkworm, has emerged as a preferred biomaterial due to its unique combination of mechanical strength, minimal immunogenicity, and versatility in various forms such as films, sponges, hydrogels, nanoparticles, and scaffolds.The rising prevalence of chronic diseases, advancements in tissue engineering, and the surging need for advanced wound care and drug delivery systems are collectively propelling the market forward. Additionally, ongoing innovations in silk fibroin processing technologies and the expanding adoption of silk-based products in cosmetics further underscore the robust growth trajectory of this market on a global scale.Source: https://researchintelo.com/report/silk-fibroin-biomaterial-market